Abstract
Nonketotic Hyperglycinemia is an autosomal recessive disorder characterized by defects in the mitochondrial glycine cleavage system. Most patients present soon after birth with seizures and hypotonia, and infants that survive the newborn period often have profound intellectual disability and intractable seizures. Here we present a case report of a 4-year-old girl with NKH as well as hyperammonemia, an uncommon finding in NKH. Genetic analysis found a previously unreported homozygous mutation (c.878–1 G > A) in the AMT gene. Maximum Entropy Principle modeling predicted that this mutation most likely breaks the splice site at the border of intron 7 and exon 8 of the AMT gene. Treatment with L-Arginine significantly reduced both the proband’s glycine and ammonia levels, in turn aiding in control of seizures and mental status. This is the first time the use of L-Arginine is reported to successfully treat elevated glycine levels.
This is a preview of subscription content, log in via an institution to check access.
References
Applegarth DA, Toone JR (2001) Nonketotic hyperglycinemia (Glycine encephalopathy): laboratory diagnosis. Mol Genet Metab 74:139–146. https://doi.org/10.1007/978-3-540-28785-8_24
Applegarth DA, Toone JR (2004) Glycine encephalopathy (nonketotic hyperglycinaemia): review and update. J Inherit Metab Dis 27(3):417–422. https://doi.org/10.1023/B:BOLI.0000031222.38328.59
Belcastro V, Barbarini M, Barca S, Mauro I (2016) A novel AMT gene mutation in a newborn with nonketotic hyperglycinemia and early myoclonic encephalopathy. Eur J Paediatr Neurol 20(1):192–195. https://doi.org/10.1016/j.ejpn.2015.08.008
Chang Y-T, Lin WD, Chin ZN, Wang CS, Chou IC, Kuo HT, Tsai FJ (2012) Nonketotic hyperglycinemia: a case report and brief review. Biomedicine 2(2):80–82. https://doi.org/10.1016/j.biomed.2012.04.002
Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C (2009) Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37(9):e67. https://doi.org/10.1093/nar/gkp215
Eagle H (1959) Amino acid metabolism in mammalian cell cultures. Science 130(3373):432–437 Available at: http://www.jstor.org/stable/1758037
Fahey JL (1957) Toxicity and blood ammonia rise resulting from intravenous amino acid administration in man: the protective effect of l-arginine. J Clin Invest 36(12):1647–1655
Farriaux J, Morel P, Hommes F (1976) Letter to the editor: neonketotic hyperglycinemia with increased proprionic acid excretion and hyperammonemia. N Engl J Med 294(10):558–559
Gross MD, Eggen MA, Simon AM, van Pilsum JF (1986) The purification and characterization of human kidney L-arginine:glycine amidinotransferase. Arch Biochem Biophys 251(2):747–755 Available at: http://www.ncbi.nlm.nih.gov/pubmed/3800397
Iqbal M, Prasad M, Mordekar SR (2015) Nonketotic hyperglycinemia case series. J Pediatr Neurosci 10(4):355–358. https://doi.org/10.4103/1817-1745.174445
Kikuchi BG et al (2008) Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia. 84:246–263. https://doi.org/10.2183/pjab/84.246
Kure S, Tada K, Narisawa K (1997) Nonketotic hyperglycinemia: biochemical, molecular, and neurological aspects. Jpn J Hum Genet 42(1):13–22. https://doi.org/10.1007/BF02766917
Madu AE, Oliver L (2013) Non-ketotic hyperglycinaemia: case report and review of medical literature. J Matern Fetal Neonatal Med 26(5):537–539. https://doi.org/10.3109/14767058.2012.745496
Okamura-Ikeda K, Hosaka H, Yoshimura M, Yamashita E, Toma S, Nakagawa A, Fujiwara K, Motokawa Y, Taniguchi H (2005) Crystal structure of human T-protein of glycine cleavage system at 2.0 ?? Resolution and its implication for understanding non-ketotic hyperglycinemia. J Mol Biol 351(5):1146–1159. https://doi.org/10.1016/j.jmb.2005.06.056
Schiffmann R, Boneh A, Ergaz Z, Glick B (1992) Nonketotic hyperglycinemia presenting with pin-point pupils and hyperammonemia. Isr J Med Sci 28(2):91–93 Available at: http://www.ncbi.nlm.nih.gov/pubmed/1559802
Toone JR, Applegarth DA, Coulter-Mackie MB, James ER (2000) Biochemical and molecular investigations of patients with nonketotic hyperglycinemia. Mol Genet Metab 70(2):116–121. https://doi.org/10.1006/mgme.2000.3000
Toone, J. R. et al. (2001) Identification of the first reported splice site mutation (IVS7-1G-->A) in the aminomethyltransferase (T-protein) gene (AMT) of the glycine cleavage complex in 3 unrelated families with nonketotic hyperglycinemia. Hum Mutat, 17(July), p. 76. https://doi.org/10.1002/1098-1004(2001)17:1<76::AID-HUMU17>3.0.CO;2-0
Toone JR, Applegarth DA, Levy HL, Coulter-Mackie MB, Lee G (2003) Molecular genetic and potential biochemical characteristics of patients with T-protein deficiency as a cause of glycine encephalopathy (NKH). Mol Genet Metab 79(4):272–280. https://doi.org/10.1016/S1096-7192(03)00115-X
Tsai KN, Wang D (2012) Identification of activated cryptic 5′ splice sites using structure profiles and odds measure. Nucleic Acids Res 40(10):e73. https://doi.org/10.1093/nar/gks061
von Wendt, L. et al. (1978) Nonketotic hyperglycinemia: a clinical analysis of 19 Finnish patients.. Monogr Hum Genet, 9(Jan), pp. 58–64
Wada Y, Tada K, Takada G, Omura K, Yoshida T (1972) Hyperglycinemia associated with hyperammonemia: in vitro glycine cleavage in liver. Pediatr Res 6:622–625
Walker JL, Oliver DJ (1986) Glycine decarboxylase multienzyme complex. Purification and partial characterization from pea leaf mitochondria. J Biol Chem 261(5):2214–2221. https://doi.org/10.1016/0003-9861(86)90517-5
Yeo G, Burge CB (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 11(2–3):377–394. https://doi.org/10.1089/1066527041410418
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to disclose.
Rights and permissions
About this article
Cite this article
Silverstein, S., Veerapandiyan, A., Hayes-Rosen, C. et al. A novel intronic homozygous mutation in the AMT gene of a patient with nonketotic hyperglycinemia and hyperammonemia. Metab Brain Dis 34, 373–376 (2019). https://doi.org/10.1007/s11011-018-0317-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-018-0317-0